Drug Profile
Research programme: transforming growth factor beta-1 receptor antagonists - Biogen Idec
Alternative Names: SM-16Latest Information Update: 24 Feb 2011
Price :
$50
*
At a glance
- Originator Biogen Idec
- Class Small molecules
- Mechanism of Action Transforming growth factor beta1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer